Identification of CD4
Algorithms
Animals
Antibodies, Bacterial
/ immunology
Bacterial Load
/ immunology
Bacterial Vaccines
/ immunology
CD4-Positive T-Lymphocytes
/ immunology
Cell Proliferation
/ physiology
Computational Biology
Epitopes, T-Lymphocyte
/ immunology
Female
Glyceraldehyde-3-Phosphate Dehydrogenases
/ genetics
Interferon-gamma
/ immunology
Mice
Mice, Inbred BALB C
Staphylococcal Infections
/ immunology
Staphylococcus aureus
/ genetics
CD4(+) T cell epitopes
Glyceraldehyde-3-phosphate dehydrogenase-C
Staphylococcus aureus
Journal
Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
16
09
2019
revised:
13
03
2020
accepted:
17
03
2020
pubmed:
31
3
2020
medline:
15
4
2021
entrez:
31
3
2020
Statut:
ppublish
Résumé
Glyceraldehyde-3-phosphate dehydrogenase-C (GapC) is a highly conserved surface protein of Staphylococcus aureus, with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity, which represents an excellent vaccine candidate antigen. It can induce protective immune responses to S. aureus infections. However, CD4
Identifiants
pubmed: 32222538
pii: S0882-4010(20)30454-X
doi: 10.1016/j.micpath.2020.104167
pii:
doi:
Substances chimiques
Antibodies, Bacterial
0
Bacterial Vaccines
0
Epitopes, T-Lymphocyte
0
IFNG protein, mouse
0
Interferon-gamma
82115-62-6
Glyceraldehyde-3-Phosphate Dehydrogenases
EC 1.2.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104167Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.